Study: Under-the-tongue therapy benefits allergy sufferers

12/21/2006 | Reuters

A report says under-the-tongue immunotherapy is cost-effective to treat adults with pollen-induced respiratory allergies. Researchers reviewing the therapy, which is undergoing clinical trails in the U.S., said they found that the treatment can lead to savings by reducing rhinitis and drug consumption.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC